On Jun. 26, 2020, Vaxart announced that its oral COVID-19 vaccine had been selected to participate in a non-human primate challenge study, organized and funded by Operation Warp Speed, a new national program aiming to provide substantial quantities of safe, effective vaccine for Americans by January 2021. The study is designed to demonstrate the efficacy of Vaxartﾒs oral COVID-19 vaccine candidate.